Bullfrog Ai(NASDAQ) BFRGW

Bullfrog AI Holdings, Inc. is a digital biopharmaceutical company focused on leveraging artificial intelligence (AI) and machine learning (ML) to analyze medical and healthcare datasets. The company’s proprietary platform, bfLEAP, is designed for processing preclinical and clinical research data, enhancing the efficiency of drug development.

Products and Services

• bfLEAP: An advanced AI/ML platform for healthcare data analysis
• Licensing agreements with George Washington University and Johns Hopkins University
• Research and development in therapeutic treatments for various human conditions

Growth Outlook

• Recent revenue of $215,385 indicates potential for growth in the healthcare sector
• Strong cash position with $6.9 million in cash and cash equivalents
• Partnerships with leading universities enhance research capabilities and market reach

Financial Highlights

• Quarterly revenue increased significantly from $0 to $215,385 in Q2 2026
• Operating expenses totaled $1.5 million, reflecting ongoing investment in R&D
• Cash flow from financing activities was $3.35 million, indicating strong investor interest

Bullfrog AI Holdings, Inc. operates in the healthcare information services industry, focusing on innovative solutions that utilize AI and ML technologies. The company has established significant partnerships with prestigious institutions, which not only validate its technology but also expand its research capabilities. The recent quarterly revenue growth demonstrates the potential for future profitability as the company continues to develop its offerings. With a solid cash position, Bullfrog AI is well-positioned to invest in further research and development, aiming to address critical healthcare challenges. The financial data reflects a commitment to growth, with substantial investments in operational capabilities and strategic partnerships that could lead to increased market presence and revenue generation.